• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板黏附和活化的分子机制

Molecular mechanisms of platelet adhesion and activation.

作者信息

Andrews R K, López J A, Berndt M C

机构信息

Hazel and Pip Appel Vascular Biology Laboratory, Baker Medical Research Institute, Prahran, Victoria, Australia.

出版信息

Int J Biochem Cell Biol. 1997 Jan;29(1):91-105. doi: 10.1016/s1357-2725(96)00122-7.

DOI:10.1016/s1357-2725(96)00122-7
PMID:9076944
Abstract

When a blood vessel is injured, control of bleeding starts with the rapid adhesion of circulating platelets to the site of damage. Within seconds, the adhered platelets are activated, secrete the contents of storage organelles, spread out over the damaged area and recruit more platelets to the developing thrombus. However, if this same process occurs in a diseased, sclerotic or occluded vessel, the resulting platelet thrombus may break away and block the coronary artery, causing a heart attack, or restrict blood supply to the brain, causing a stroke. The glycoprotein (GP) Ib-IX-V complex, a member of the leucine-rich protein family, is a constitutive platelet membrane receptor for von Willebrand Factor (vWF), a multimeric adhesive glycoprotein found in the matrix underlying the endothelial cell lining of the blood vessel wall and in the plasma. Binding of vWF to the GP. Ib-IX-V complex regulates adhesion of platelets to the subendothelium at high shear flow, and initiates signal transduction leading to platelet activation. The GP Ib-IX-V complex also constitutes a binding site for alpha-thrombin, an interaction that facilitates thrombin-dependent platelet activation. This review will focus on recent detailed analysis of the GP Ib-IX-V complex and vWF that has identified discrete amino acid sequences that mediate their interaction. An anionic/sulfated tyrosine sequence of the GP Ib alpha-chain that is critical for binding of the GP Ib-IX-V complex to both vWF and alpha-thrombin is analogous to sulfated anionic amino acid sequences mediating interactions of other adhesive proteins, including P-selectin binding to PSGL-1 and Factor VIII binding to vWF.

摘要

当血管受损时,止血过程始于循环中的血小板迅速黏附到损伤部位。数秒内,黏附的血小板被激活,分泌储存细胞器的内容物,在损伤区域铺展并募集更多血小板至正在形成的血栓处。然而,如果同样的过程发生在病变、硬化或闭塞的血管中,形成的血小板血栓可能会脱落并阻塞冠状动脉,导致心脏病发作,或限制脑部血液供应,引发中风。糖蛋白(GP)Ib-IX-V复合物是富含亮氨酸蛋白家族的成员,是血管性血友病因子(vWF)的组成型血小板膜受体,vWF是一种多聚体黏附糖蛋白,存在于血管壁内皮细胞内衬下方的基质以及血浆中。vWF与GP Ib-IX-V复合物的结合在高剪切流条件下调节血小板与内皮下的黏附,并启动导致血小板激活的信号转导。GP Ib-IX-V复合物也是α-凝血酶的结合位点,这种相互作用促进凝血酶依赖性血小板激活。本综述将聚焦于对GP Ib-IX-V复合物和vWF的最新详细分析,这些分析确定了介导它们相互作用的离散氨基酸序列。GP Ibα链的一个阴离子/硫酸化酪氨酸序列对于GP Ib-IX-V复合物与vWF和α-凝血酶的结合至关重要,它类似于介导其他黏附蛋白相互作用的硫酸化阴离子氨基酸序列,包括P-选择素与PSGL-1的结合以及因子VIII与vWF的结合。

相似文献

1
Molecular mechanisms of platelet adhesion and activation.血小板黏附和活化的分子机制
Int J Biochem Cell Biol. 1997 Jan;29(1):91-105. doi: 10.1016/s1357-2725(96)00122-7.
2
Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex.表达血小板糖蛋白Ib-IX-V复合物的哺乳动物细胞在血管性血友病因子上的剪切依赖性滚动
Blood. 1998 Nov 15;92(10):3684-93.
3
Platelet adhesion receptors and (patho)physiological thrombus formation.血小板黏附受体与(病理)生理性血栓形成。
Histol Histopathol. 2001 Jul;16(3):969-80. doi: 10.14670/HH-16.969.
4
Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.来自白唇竹叶青的一种新型50千道尔顿白聚蛋白及相关蝰蛇毒蛋白与血小板膜糖蛋白Ib-IX-V复合物的结合。对血小板聚集和糖蛋白Ib介导的血小板活化的影响。
Biochemistry. 1996 Sep 24;35(38):12629-39. doi: 10.1021/bi960704e.
5
Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex.纯化的14-3-3 ζ信号蛋白与血小板膜糖蛋白Ib-IX-V复合物胞质结构域内离散氨基酸序列的结合。
Biochemistry. 1998 Jan 13;37(2):638-47. doi: 10.1021/bi970893g.
6
Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.莫卡哈金,一种新型眼镜蛇毒金属蛋白酶,可裂解血小板血管性血友病因子受体糖蛋白Ibalpha。鉴定糖蛋白Ibalpha的硫酸化酪氨酸/阴离子序列Tyr-276-Glu-282作为血管性血友病因子和α-凝血酶的结合位点。
Biochemistry. 1996 Apr 16;35(15):4929-38. doi: 10.1021/bi952456c.
7
Glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3): effects of receptor clustering and von Willebrand factor adhesion.糖蛋白Ib-IX介导的整合素α(IIb)β(3)激活:受体聚集和血管性血友病因子黏附的影响
J Thromb Haemost. 2003 Jun;1(6):1150-7. doi: 10.1046/j.1538-7836.2003.00295.x.
8
ADAP is required for normal alphaIIbbeta3 activation by VWF/GP Ib-IX-V and other agonists.VWF/GP Ib-IX-V和其他激动剂正常激活αIIbβ3需要ADAP。
Blood. 2007 Feb 1;109(3):1018-25. doi: 10.1182/blood-2006-05-022301. Epub 2006 Sep 26.
9
The vascular biology of the glycoprotein Ib-IX-V complex.糖蛋白Ib-IX-V复合物的血管生物学
Thromb Haemost. 2001 Jul;86(1):178-88.
10
von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.高纯度FVIII浓缩物(Fanhdi)中含有的血管性血友病因子可与血小板糖蛋白结合,并在流动条件下支持血小板黏附于内皮下层。
Haematologica. 1999 Jan;84(1):5-11.

引用本文的文献

1
Low LDL-Cholesterol and Hemorrhagic Risk: Mechanistic Insights and Clinical Perspectives.低低密度脂蛋白胆固醇与出血风险:机制洞察与临床视角
Int J Mol Sci. 2025 Jun 11;26(12):5612. doi: 10.3390/ijms26125612.
2
Microfluidic transection injury and high-shear thrombus formation demonstrate increased hemostatic efficacy of cold-stored platelets and resuscitation in induced coagulopathy models.微流控横断损伤和高剪切力血栓形成表明,在诱导性凝血病模型中,冷储存血小板和复苏的止血效果增强。
Front Bioeng Biotechnol. 2025 May 12;13:1568113. doi: 10.3389/fbioe.2025.1568113. eCollection 2025.
3
Venous Thromboembolism: Current Insights and Future Directions.
静脉血栓栓塞症:当前见解与未来方向
Int J Angiol. 2024 Jul 8;33(4):250-261. doi: 10.1055/s-0044-1787652. eCollection 2024 Dec.
4
Detection of cellular traction forces via the force-triggered Cas12a-mediated catalytic cleavage of a fluorogenic reporter strand.通过力触发的 Cas12a 介导的荧光报告分子链的催化切割来检测细胞牵引力。
Nat Biomed Eng. 2023 Nov;7(11):1404-1418. doi: 10.1038/s41551-023-01114-1. Epub 2023 Nov 13.
5
Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke.急性缺血性脑卒中静脉注射阿替普酶溶栓治疗 1 年不良结局的决定因素。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231187616. doi: 10.1177/10760296231187616.
6
Patient specific approach to analysis of shear-induced platelet activation in haemodialysis arteriovenous fistula.针对血液透析动静脉瘘中剪切诱导血小板活化的患者特异性分析方法。
PLoS One. 2022 Oct 3;17(10):e0272342. doi: 10.1371/journal.pone.0272342. eCollection 2022.
7
Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation.超越止血:血小板的固有免疫相互作用与血栓炎症
Int J Mol Sci. 2022 Mar 31;23(7):3868. doi: 10.3390/ijms23073868.
8
Low Bone Mineral Density in Hemophiliacs.血友病患者的低骨矿物质密度
Front Med (Lausanne). 2022 Feb 2;9:794456. doi: 10.3389/fmed.2022.794456. eCollection 2022.
9
Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy.细胞膜表面工程化的纳米载体用于癌症靶向化疗。
J Nanobiotechnology. 2022 Jan 21;20(1):45. doi: 10.1186/s12951-022-01251-w.
10
Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation.细胞膜包覆模拟物:用于治疗应用的制造、表征的方法学方法,以及临床转化的挑战。
ACS Nano. 2021 Nov 23;15(11):17080-17123. doi: 10.1021/acsnano.1c03800. Epub 2021 Oct 26.